Pharming Group has announced that the US Food and Drug Administration (FDA) has accepted its supplemental New Drug ...
What constitutes a positive outcome for patients does not always align with the outcomes of interest to researchers’ ...
Micheal Tague, President of Porterhouse Medical US, commented: “We are thrilled to welcome Jennifer to the team. Her ...
The US Food and Drug Administration (FDA) has approved Eli Lilly’s Inluriyo (imlunestrant) to treat advanced or metastatic ...